Update on emerging biomarkers in lung cancer

Keyphrases

• Lung Cancer 100%
• Emerging Biomarkers 100%
• Therapeutic Agents 50%
• Locally Advanced Non-small Cell Lung Cancer (LA-NSCLC) 50%
• Clinically Significant 50%
• Disease Control 50%
• Treatment Decisions 50%
• Targeted Therapy 50%
• Biomarker Testing 50%
• Current Guidelines 50%
• Medical Oncologist 50%
• Molecular Subgroups 50%
• Driver mutations 50%

Medicine and Dentistry

• Lung Cancer 100%
• Biological Marker 100%
• Diseases 33%
• Therapeutic Agent 33%
• Targeted Therapy 33%
• Oncologist 33%

Pharmacology, Toxicology and Pharmaceutical Science

• Lung Cancer 100%
• Biological Marker 100%
• Diseases 33%